National Coverage Analysis (NCA)

Autologous Cellular Immunotherapy Treatment of Metastatic Prostate Cancer

CAG-00422N

Expand All | Collapse All

Contacts

CAG Resource Box
caginquiries@cms.hhs.gov
Lead Analysts
Lead Medical Officers

History of Considerations

History Title ID
Original Consideration Autologous Cellular Immunotherapy Treatment of Metastatic Prostate Cancer CAG-00422N You are here